SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010760
Filing Date
2023-03-30
Accepted
2023-03-30 08:46:19
Documents
89
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cadl-20221231.htm   iXBRL 10-K 3671143
2 EX-10.16 cadl-ex10_16.htm EX-10 479131
3 EX-23.1 cadl-ex23_1.htm EX-23 3324
4 EX-31.1 cadl-ex31_1.htm EX-31 17750
5 EX-31.2 cadl-ex31_2.htm EX-31 17767
6 EX-32.1 cadl-ex32_1.htm EX-32 19382
7 GRAPHIC img212077252_0.jpg GRAPHIC 78669
  Complete submission text file 0000950170-23-010760.txt   12435003

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cadl-20221231_def.xml EX-101.DEF 271674
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cadl-20221231_cal.xml EX-101.CAL 53607
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cadl-20221231_lab.xml EX-101.LAB 597482
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cadl-20221231.xsd EX-101.SCH 75642
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cadl-20221231_pre.xml EX-101.PRE 454419
83 EXTRACTED XBRL INSTANCE DOCUMENT cadl-20221231_htm.xml XML 1877036
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40629 | Film No.: 23777313
SIC: 2836 Biological Products, (No Diagnostic Substances)